Koyfin Home > Directory > Health Care > Amicus Therapeutics > EBITDA Margin

Amicus Therapeutics EBITDA Margin Chart (FOLD)

Amicus Therapeutics annual/quarterly EBITDA Margin from 2008 to 2018. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Amicus Therapeutics EBITDA Margin for the quarter ending December 12, 2018 was $-208m a 36.06% decrease of -75m year over year
  • Amicus Therapeutics EBITDA Margin for the last 12 months ending December 12, 2012 was $-278m a 27.67% decrease of -77m year over year
  • Amicus Therapeutics Annual EBITDA Margin for 2012 was $-278m a 22.85% decrease of -64m from 2011
  • Amicus Therapeutics Annual EBITDA Margin for 2011 was $-215m a 97.32% decrease of -209m from 2010
  • Amicus Therapeutics Annual EBITDA Margin for 2009 was $-6m a -4,840.29% increase of 278m from 2008
Other Margins & Efficiency Metrics:
  • Amicus Therapeutics Return on Capital % for the quarter ending September 09, 2018 was -53.00 a 52.45% decrease of -27.80 year over year
  • Amicus Therapeutics Return on Equity % for the quarter ending September 09, 2018 was -130.88 a 44.52% decrease of -58.28 year over year
View Chart On Koyfin

Quarterly FOLD EBITDA Margin Data

12/2018$-208m
06/2018$-214m
06/2012$-84m
03/2012$-133m
12/2011$-167m
09/2011$-210m
03/2011$-160m
12/2009$71m
09/2009$-263m
06/2009$-249m

Annual FOLD EBITDA Margin Data

2012$-278m
2011$-215m
2009$-6m
2008$-284m